| Shannon Clarke Campbell Nedelka, MD | |
|
7 Dreyer Way, Rochester, NH 03867-2775 | |
| (603) 332-6413 | |
| (603) 335-1076 |
| Full Name | Shannon Clarke Campbell Nedelka |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 26 Years |
| Location | 7 Dreyer Way, Rochester, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174514509 | NPI | - | NPPES |
| 30205273 | Medicaid | NH | |
| 01Y008533NH01 | Other | NH | ANTHEM BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 12807 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital | Belleville, IL | Hospital |
| Alton Memorial Hospital | Alton, IL | Hospital |
| Greene County General Hospital | Linton, IN | Hospital |
| Clay County Hospital | Flora, IL | Hospital |
| Fayette County Hospital | Vandalia, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Radiologists Sc | 3476540873 | 42 |
| Clinical Radiologists Sc | 3476540873 | 42 |
| John Fitzgibbon Memorial Hospital Inc | 2567351570 | 86 |
| Clinical Radiologists Sc | 3476540873 | 42 |
| Clinical Radiologists Sc | 3476540873 | 42 |
News Archive
Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene's Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.
VitaPath Genetics, a molecular diagnostics company, announced today that it has closed a $6 million series A round of funding led by MDV-Mohr Davidow Ventures. VitaPath was originally seeded by X/Seed Capital, which also co-invested in the Series A. Concurrent with the financing MDV's Michael Goldberg and X/Seed's Michael Borrus took seats on the company's board.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.
Abbott today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer.
University of Pennsylvania School of Medicine physicians and bioethicists are calling for a new, more standardized way for patients in need of organ transplants to be informed of the risks they face. If adopted, their policy recommendations could promote greater equity in how organs are allocated while restricting patients' abilities to "cherry-pick" the best organs.
› Verified 2 days ago
| Entity Name | Seacoast Radiology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427020395 PECOS PAC ID: 3274500541 Enrollment ID: O20040915000779 |
News Archive
Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene's Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.
VitaPath Genetics, a molecular diagnostics company, announced today that it has closed a $6 million series A round of funding led by MDV-Mohr Davidow Ventures. VitaPath was originally seeded by X/Seed Capital, which also co-invested in the Series A. Concurrent with the financing MDV's Michael Goldberg and X/Seed's Michael Borrus took seats on the company's board.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.
Abbott today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer.
University of Pennsylvania School of Medicine physicians and bioethicists are calling for a new, more standardized way for patients in need of organ transplants to be informed of the risks they face. If adopted, their policy recommendations could promote greater equity in how organs are allocated while restricting patients' abilities to "cherry-pick" the best organs.
› Verified 2 days ago
| Entity Name | Clinical Radiologists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063469252 PECOS PAC ID: 3476540873 Enrollment ID: O20230112000163 |
News Archive
Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene's Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.
VitaPath Genetics, a molecular diagnostics company, announced today that it has closed a $6 million series A round of funding led by MDV-Mohr Davidow Ventures. VitaPath was originally seeded by X/Seed Capital, which also co-invested in the Series A. Concurrent with the financing MDV's Michael Goldberg and X/Seed's Michael Borrus took seats on the company's board.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.
Abbott today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer.
University of Pennsylvania School of Medicine physicians and bioethicists are calling for a new, more standardized way for patients in need of organ transplants to be informed of the risks they face. If adopted, their policy recommendations could promote greater equity in how organs are allocated while restricting patients' abilities to "cherry-pick" the best organs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Clarke Campbell Nedelka, MD 7 Dreyer Way, Rochester, NH 03867-2775 Ph: (603) 332-6413 | Shannon Clarke Campbell Nedelka, MD 7 Dreyer Way, Rochester, NH 03867-2775 Ph: (603) 332-6413 |
News Archive
Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene's Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.
VitaPath Genetics, a molecular diagnostics company, announced today that it has closed a $6 million series A round of funding led by MDV-Mohr Davidow Ventures. VitaPath was originally seeded by X/Seed Capital, which also co-invested in the Series A. Concurrent with the financing MDV's Michael Goldberg and X/Seed's Michael Borrus took seats on the company's board.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.
Abbott today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer.
University of Pennsylvania School of Medicine physicians and bioethicists are calling for a new, more standardized way for patients in need of organ transplants to be informed of the risks they face. If adopted, their policy recommendations could promote greater equity in how organs are allocated while restricting patients' abilities to "cherry-pick" the best organs.
› Verified 2 days ago
Shawn M Rayder, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7 Dreyer Way, Rochester, NH 03867 Phone: 603-332-6413 Fax: 603-335-1076 | |
Mai-huong T Tran, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 7 Dreyer Way, Rochester, NH 03867 Phone: 603-332-6413 Fax: 603-335-1076 | |
Bernard M Casey, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 7 Dreyer Way, Rochester, NH 03867 Phone: 603-332-6413 Fax: 603-335-1076 | |
Sharon A Marshall, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 7 Dreyer Way, Rochester, NH 03867 Phone: 603-332-6413 Fax: 603-335-1076 | |
Brian J Szymanski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7 Dreyer Way, Rochester, NH 03867 Phone: 603-332-6413 Fax: 603-335-1076 | |
Burns E Foley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7 Dreyer Way, Rochester, NH 03867 Phone: 603-332-6413 Fax: 603-335-1076 |